1. Bazill GW, Dexter TM (1990) Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDP-Mix A4 cells. Cancer Res 50: 7505?7512
2. Berdel WE (1991) Membrane-interactive lipids as experimental anticancer drugs. Br J Cancer 61: 208?211
3. Berdel WE, Munder PG (1987) Anti-neoplastic action of ether lipids related to platelet-activating factor. In: Snyder F (ed) Platelet activating factor and related lipid mediators. Plenum, New York, pp 449?467
4. Berdel WE, Becher R, Edler L, Bremer K, Essers U, Drozd A, Zafferani M, Klee MAG, Bachmann P, Korfel A, Westerhausen M (1992) Daily oral Miltefosine (hexadecyl-phosphocholine) in patients with advanced non-small cell lung cancer. A phase II study. Onkologie 15: 238?242
5. Daniel LW (1993) Ether lipids in experimental cancer chemotherapy. In: Hickman JA, Tritton TR (eds) Cancer chemotherapy, ch 6. Blackwell, Oxford, pp 146?178